FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3127979085> ?p ?o ?g. }

• W3127979085 endingPage "45" @default.
• W3127979085 startingPage "44" @default.
• W3127979085 abstract "Aspirin is perceived to be non-inferior to enoxaparin, a low-molecular-weight heparin, for the prevention of venous thromboembolism (VTE) following elective arthroplasty of the hip or knee and is recommended in clinical guidelines internationally. Previous systematic reviews of aspirin as VTE prophylaxis have been limited by the inclusion of heterogenous studies where aspirin is commenced after the initial high-risk postoperative period. The purpose of this systematic review and meta-analysis was to compare the efficacy and associated harms of aspirin and enoxaparin when used as VTE prophylaxis in the initial postoperative period following elective arthroplasty of the hip or knee. We sought to: 1) to compare the use of aspirin versus enoxaparin following elective joint replacement of the hip or knee on the primary outcomes of incidence of VTE and mortality up to 3 months postoperatively; 2) assess the efficacy of aspirin with respect to secondary outcomes such as major or minor bleeding events. We hypothesised that aspirin would have equivalent efficacy for the prevention of VTE when used as initial prophylactic agent, without increasing harm from bleeding events. We searched Pubmed, Embase, Medline and Cochrane CENTRAL for randomized controlled trials reporting the primary outcomes of VTE incidence and mortality. Secondary outcomes included major (compromise of organ, limb or muscle function requiring unplanned re-operation) and minor bleeding events (wound ooze, minor bleed, infection). Included trials underwent a risk of bias and quality of evidence assessment using the GRADE criteria. Four trials involving 1507 participants who underwent elective lower limb arthroplasty were included. We did not detect a significant difference in overall VTE rates when comparing aspirin versus enoxaparin (RR, 0.84; 95% CI: 0.41 to 1.75; p = 0.65). Mortality was reported by one study and no events were recorded. There were no significant differences in the rates of all major (RR, 0.84; 95% CI: 0.08 to 9.16) or minor (RR, 0.77; 95% CI: 0.34 to 1.72) bleeding events between the aspirin and enoxaparin groups. Included trials demonstrated a significant risk of bias, and low to very low quality of evidence for primary outcomes, and moderate to very low for secondary outcomes. There is currently a lack of high quality randomised controlled trials supporting the use of aspirin as VTE chemoprophylaxis in the initial postoperative period for both total hip and total knee arthroplasty. The results of this meta-analysis provide cautious endorsement for the position that aspirin is likely a safe alternative to enoxaparin for TKA patients as part of a multimodal enhanced recovery protocol, but care is advised for THA patients owing to a lack of data from trials, as current evidence from randomized controlled trials is generally of low quality, and does not estimate critical event data for VTE incidence or mortality, as well as major and minor bleeding events with sufficient certainty. PROSPERO Registration CRD42018110784. II, systematic review." @default.
• W3127979085 created "2021-02-15" @default.
• W3127979085 creator A5025380607 @default.
• W3127979085 creator A5034546168 @default.
• W3127979085 creator A5064560162 @default.
• W3127979085 creator A5082242702 @default.
• W3127979085 creator A5082662051 @default.
• W3127979085 date "2021-02-01" @default.
• W3127979085 modified "2023-09-27" @default.
• W3127979085 title "Aspirine versus enoxaparine pour la prévention initiale des accidents thromboemboliques veineux après arthroplastie primaire programmée de la hanche ou du genou : revue systématique et méta-analyse" @default.
• W3127979085 doi "https://doi.org/10.1016/j.rcot.2020.04.010" @default.
• W3127979085 hasPublicationYear "2021" @default.
• W3127979085 type Work @default.
• W3127979085 sameAs 3127979085 @default.
• W3127979085 citedByCount "0" @default.
• W3127979085 crossrefType "journal-article" @default.
• W3127979085 hasAuthorship W3127979085A5025380607 @default.
• W3127979085 hasAuthorship W3127979085A5034546168 @default.
• W3127979085 hasAuthorship W3127979085A5064560162 @default.
• W3127979085 hasAuthorship W3127979085A5082242702 @default.
• W3127979085 hasAuthorship W3127979085A5082662051 @default.
• W3127979085 hasConcept C120665830 @default.
• W3127979085 hasConcept C121332964 @default.
• W3127979085 hasConcept C126322002 @default.
• W3127979085 hasConcept C141071460 @default.
• W3127979085 hasConcept C2776884760 @default.
• W3127979085 hasConcept C2777628954 @default.
• W3127979085 hasConcept C2778336525 @default.
• W3127979085 hasConcept C2780868729 @default.
• W3127979085 hasConcept C61511704 @default.
• W3127979085 hasConcept C71924100 @default.
• W3127979085 hasConceptScore W3127979085C120665830 @default.
• W3127979085 hasConceptScore W3127979085C121332964 @default.
• W3127979085 hasConceptScore W3127979085C126322002 @default.
• W3127979085 hasConceptScore W3127979085C141071460 @default.
• W3127979085 hasConceptScore W3127979085C2776884760 @default.
• W3127979085 hasConceptScore W3127979085C2777628954 @default.
• W3127979085 hasConceptScore W3127979085C2778336525 @default.
• W3127979085 hasConceptScore W3127979085C2780868729 @default.
• W3127979085 hasConceptScore W3127979085C61511704 @default.
• W3127979085 hasConceptScore W3127979085C71924100 @default.
• W3127979085 hasIssue "1" @default.
• W3127979085 hasLocation W31279790851 @default.
• W3127979085 hasOpenAccess W3127979085 @default.
• W3127979085 hasPrimaryLocation W31279790851 @default.
• W3127979085 hasRelatedWork W1260428 @default.
• W3127979085 hasRelatedWork W1376558 @default.
• W3127979085 hasRelatedWork W14560129 @default.
• W3127979085 hasRelatedWork W17334203 @default.
• W3127979085 hasRelatedWork W17716312 @default.
• W3127979085 hasRelatedWork W17908223 @default.
• W3127979085 hasRelatedWork W2517882 @default.
• W3127979085 hasRelatedWork W6979254 @default.
• W3127979085 hasRelatedWork W7748005 @default.
• W3127979085 hasRelatedWork W883012 @default.
• W3127979085 hasVolume "107" @default.
• W3127979085 isParatext "false" @default.
• W3127979085 isRetracted "false" @default.
• W3127979085 magId "3127979085" @default.
• W3127979085 workType "article" @default.